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The entry of Moloney murine leukemia virus (MoMuLV) to murine cells is mediated by the binding of its envelope
glycoprotein gp70 to its receptor, the cationic amino acid transporter MCAT-1. The binding property of the envelope protein
lies mainly in the N-terminal half of the protein. To identify essential residues involved in the binding of gp70 to its receptor,
we have mutated amino acids within the putative receptor-binding domain of MoMuLV gp70. Changes in the residues P94
and W100 resulted in lower viral titers in comparison to the wild-type virions. Single, double, or triple point mutations involving
the residue W100 make the envelope protein severely defective in binding to its receptor. Binding studies and cell fusion
experiments with murine XC cells suggested that the residue W100 might play an important role in the process of infection
by making contact between gp70 and its receptor. © 2000 Academic PressINTRODUCTION
Attachment of MuLV virions to the surface of the cells
occurs through the specific interaction between the en-
velope glycoprotein and its cellular receptor (Albritton et
al., 1989). The envelope glycoprotein complex of replica-
tion-competent MuLV is composed of two polypeptides.
One is the glycosylated external hydrophilic polypeptide,
termed surface glycoprotein gp70 (SU), and the other is
the membrane-spanning, hydrophobic transmembrane
protein p15E (TM). Both of these polypeptides are syn-
thesized from the same spliced RNA and the precursor
protein (gp85) is proteolytically cleaved during the as-
sembly process to give rise to both SU and TM proteins.
Murine leukemia viruses (MuLVs) are classified as
ecotropic (infecting only mouse cells) (Horowitz and Ris-
ser, 1985), amphotropic (infecting both murine and hu-
man cells) (Hartley and Rowe, 1975), xenotropic (infect-
ing only cells other than mouse cells), polytropic (mink
cell focus forming virus) (Evans and Cloyd, 1984), and the
10A1 type (having an expanded host range and binding
both amphotropic and GALV receptors) (Ott and Rein,
1992; Rein and Schultz, 1984). The receptor for the eco-
tropic MuLV has been identified as a cationic amino acid
transporter (CAT-1) with 14 membrane-spanning regions
(Albritton et al., 1989). The Moloney murine leukemia
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90virus (MoMuLV) is an ecotropic virus, the entry of which
is mediated by MCAT-1 in murine cells.
The MoMuLV envelope protein has two hypervariable
regions, VRA and VRB, that contribute to receptor recog-
nition (Battini et al., 1995; Morgan et al., 1993; Ott and
Rein, 1992). It has been suggested that the amino acids
81–88 might be responsible for the direct contact be-
tween MoMuLV gp70 and its receptor (MacKrell et al.,
1996). The residues responsible for receptor recognition
have been mapped to the first potential disulfide-linked
loop within the VRA region of the ecotropic gp70 (Bae et
al., 1997; McDougall et al., 1994). The expression of a
truncated protein containing the amino-terminal portion
of the Friend MuLV gp70 was reported to establish su-
perinfection interference, consistent with binding and
down-regulation of the receptor expression (Battini et al.,
1995). The N-terminal 236 amino acids of Friend MuLV
gp70, when expressed using the baculovirus expression
system, has been found to bind to its receptor MCAT-1
with the same affinity as the wild-type protein (Davey et
al., 1997). Other studies have identified the regions of
gp70 involved in its expression or stability (Felkner and
Roth, 1992), fusion activity (Jones and Risser, 1993; Skov
and Andersen, 1993), and receptor-binding ability (Bae et
al., 1997; MacKrell et al., 1996).
Arginine residues at positions 83 and 95 in MoMuLV
gp70 have been reported to be involved in receptor
interaction and mutations at these sites abolish the bind-
ing of gp70 to its receptor (Bae et al., 1997). The region of
the receptor required for specific interaction with the
ecotropic envelope protein lies in its third and/or fourth
extracellular domain (Yoshimoto et al., 1993). Both ty-
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91MUTATIONAL ANALYSIS OF ENVELOPE PROTEIN IN ECOTROPIC RETROVIRUSrosine 235 and glutamic acid 237 in the third extracellu-
lar loop of the receptor have been found to be important,
and mutations of both these amino acids abolish the
infection by ecotropic virus (Yoshimoto et al., 1993).
There is a possibility (Malhotra et al., 1994) that the
harged arginine residues 83 and 95 of MoMuLV gp70
ind to tyrosine 235 and glutamic acid 237 of the recep-
or and initiate the process of infection (Bae et al., 1997).
From computer modeling and structural studies on
riend MuLV’s receptor-binding domain the region of
mino acids 85–102 that forms the hydrophobic pocket
nd a charged ridge has been predicted to form the
inding pocket between the envelope and its receptor
Fass et al., 1997).
Taking the results from previous biochemical and
tructural studies, we have chosen a region of the Mo-
uLV envelope from amino acids 89 to 100 for mutagen-
sis analysis to identify important residues that play a
ey role(s) in the envelope–receptor interaction. Different
utations in the envelope protein are schematically rep-
esented in Fig. 1. Six different single point mutations,
hree double mutations, and one triple mutation were
reated in the region spanning amino acids 89–100 to
lucidate the importance of amino acids in the putative
eceptor-binding domain of MoMuLV gp70.
RESULTS
xpression of viral proteins
The level of expression of proteins in transfected cell
xtracts and envelope incorporation into viral particles
ere checked by Western blot analysis. Gag expression
as checked in the cell extracts and the viral superna-
ants as depicted from the Western blots (Fig. 2). The
xpression of Gag suggested that virions were produced
rom the cells transfected with WT as well as mutant
nvelopes. In all cases, viruses also processed the Gag
recursor into individual components and this character-
stic was unaffected by mutations in the envelope pro-
ein. All the mutants and the WT envelopes were ex-
ressed in transfected 293T cells. In all cases the pres-
nce of envelope proteins in viral particles was
naffected except in P94S and P94S/W100T, where low
evels of envelope incorporation were observed (see
ig. 2).
ole of envelope mutants in the process of infection
The initial characterization of envelope mutations was
one by testing the viral supernatants from transfected
93T cells for their ability to transduce murine NIH 3T3
ibroblasts. Transduction efficiency was measured by
ounting the number of lacZ-positive blue cells. For con-
rol experiments, the wild-type Moloney MuLV envelope
lasmid (pHIT 123) was used. For a negative control,
ells were mock transfected with MuLV gag-pol plasmid
v
apHIT 60) and vector genome with lacZ (pHIT 111) without
ny envelope. The result of the infection assay is given in
able 1. Mutations in amino acids other than 94 and 100
id not have any effect on the infection of virions on
urine fibroblasts. In the case where amino acid 94
proline) is changed to serine, a three-log reduction in
he titer was observed. Changing the amino acid from
ryptophan to threonine at position 100 also resulted in a
undredfold reduction in viral titer.
In one of the double mutants (pRV 737) where both
mino acids 91 and 100 were mutated, a thousandfold
educed viral titer was obtained. Double mutations at
ositions 93 and 100 or positions 94 and 100 (pRV 738
nd pRV 739) completely abolished viral infectivity. A
imilar pattern of infectivity was also observed when the
riple mutant (involving amino acids 89, 93, and 100, pRV
40) was used in the cotransfection experiments. A re-
FIG. 1. Schematic representation of Moloney murine leukemia virus
envelope protein with both signal peptide (SS) and the putative recep-
tor-binding region (marked as hatched area). Different mutations were
created in the region of amino acids 89–100, shown below in single-
letter code and used for functional analysis studies. The numbers on
the top and bottom indicate the number of gp70 amino acids. The
names of the expression plasmids along with the mutated amino acids
are also represented for all mutant plasmids constructed. The mutant
amino acids are represented in boldface type and underlined.erse transcriptase assay with virions carrying mutations
t their envelopes showed that equal quantities of virus
ti-gp69
92 PANDA, KINGSMAN, AND KINGSMANparticles were produced from all transfected dishes
(data not shown).
The reduction in viral titer due to single, double, or
triple mutations in the putative receptor-binding region
could have resulted either due to low binding efficiency
of the envelope protein to its receptor or due to any
change(s) in the postbinding events. In order to test
these possibilities, we carried out superinfection and
binding analyses.
Superinfection with wild-type MoMuLV particles
Superinfecting NIH 3T3 cells with wild-type virions
gave us an indication of the initial receptor-binding abil-
ities of mutant envelopes, particularly those mutations
that caused a decrease in viral titer. In mutant glycopro-
teins that retained binding ability, we expected no
change in viral titer upon superinfection. However, an
increase in titer upon superinfection could suggest a
FIG. 2. (A, B) Analysis of viral proteins by Western blot analysis. Viru
MoMuLV particles and the rest of the numbers represent particles bear
Both cell extracts (C) and viral particles (V) were probed with goat an
anti-p30 (capsid) antibody (p65gag and p30gag).loss in binding ability. Results of the superinfection assay
are given in Table 1.In all cases where a loss of viral titer had been observed
earlier (with P94S, W100T, and all double and triple mu-
tants), wild-type titers were restored upon superinfection.
This suggests that the mutant envelopes that caused a
decrease in titer were deficient in binding to their receptors.
Further direct-binding assays by FACS analysis helped us
to confirm the binding deficiency of mutant envelopes to
their receptors compared to the wild-type virions.
Binding studies with mutant envelopes
FACS analysis was performed with polyclonal anti-
gp70 antibody to check the efficiencies of the virions that
bear mutant envelopes to bind to the cellular receptors.
As seen in Fig. 3, virions bearing mutant envelope T90V,
S91A, and T93V bind to NIH 3T3 cells with nearly the
same efficiency as the wild-type virions. At the same
time, virions carrying mutations at amino acids L89P,
L92P, and T94S resulted in a reduced binding compared
les (V) were produced by three plasmid cotransfections. pHIT 123-WT
ations at corresponding amino acids in the MoMuLV envelope protein.
/71 polyclonal antisera (gp85env and gp70env) and with monoclonals partic
ing mutto the wild-type virions (see Fig. 3). Interestingly, this
binding is not strictly reflected in the viral infectivity.
93MUTATIONAL ANALYSIS OF ENVELOPE PROTEIN IN ECOTROPIC RETROVIRUSBinding to NIH3T3 cells could not be determined using
virions bearing envelopes with a mutation at amino acid
100. In this case, there is a possibility that the binding
was so poor that it was below the level of detection by
FACS analysis. For viruses bearing envelopes with either
double or triple mutations, very poor or barely detectable
binding was observed (see Fig. 3B).
As the FACS analysis represented here is not quanti-
tative, no direct correlation between the results of the
titer and the binding can be established. However, taking
transduction and superinfection data in conjunction with
the FACS analysis, it can be concluded that the muta-
tions in the envelope had altered their binding abilities,
resulting in lower infection efficiencies.
Syncytia-forming ability of mutant envelopes
The syncytia-forming capacity of ecotropic MuLV vi-
ruses is attributed to the fusion ability of its envelope
protein (Rowe et al., 1970). Syncytia are large, multinu-
cleated structures in which the cell membranes are
fused together with the nuclei at the center. It has been
shown previously that Moloney MuLVs form syncytia on
FIG. 2—ContinuedXC cells (Jones and Risser, 1993; Ragheb and Anderson,
1994). In order to test the syncytia-forming abilities of themutant envelope proteins, 293T cells were transfected
with the wild-type or individual mutant envelope plas-
mids (without any gag-pol or vector genome) and XC
cells were seeded onto the same disc 24 h posttrans-
fection. The cells were stained with methylene blue to
observe the syncytia and later photographed.
As shown in Fig. 4, all the mutant envelopes bearing
single point mutations produced syncytia. However, the
degree of syncytia formation varied in different mutant en-
velopes. In envelopes with either double or triple mutations,
the ability of gp70 to form syncytia was greatly reduced.
Results from the syncytium assays suggested that the
mutant envelopes that bound poorly to the receptors
fused to XC cells very inefficiently and formed fewer
syncytia on the cells. Similarly, the envelopes with dou-
ble and triple mutations that failed to bind to their cellular
receptors could not fuse to the XC cells at all.
DISCUSSION
The N-terminal 230 amino acids of MoMuLV gp70 are
important for binding to its cellular receptor and for the
TABLE 1
Effect of Envelope Mutations on Viral Infectivity and Superinfection
with Wild-Type MoMuLV Virions on NIH 3T3 Cells
Envelope used
Titera (CFU/ml)
on NIH 3T3
cells
Titera (CFU/ml)
after superinfection
on NIH 3T3 cellsb
pHIT 123 1.3 3 106 2.08 3 106
Wild-type
pRV 730 9.6 3 105 3.7 3 106
L89P
pRV 731 1.4 3 106 4.12 3 106
T90V
pRV 732 2.2 3 106 3.03 3 106
S91A
pRV 733 1.2 3 106 3.6 3 106
L92P
pRV 734 1.2 3 106 3.34 3 106
T93V
pRV 735 9.6 3 103 2.87 3 106
P94S
pRV 736 9.6 3 104 2.06 3 106
W100T
pRV 737 1.2 3 103 8.9 3 105
S91A/W100T
pRV 738 0 1.1 3 106
T93V/W100T
pRV 739 0 7.9 3 105
P94S/W100T
pRV 740 0 6.7 3 105
L89P/T93V/W100T
Mock 0 4.3 3 106
a Titers represented are the mean 6 SD of the replicated determi-
nants from a representative experiment of a total of three performed.
b The same cells were reinfected after viral supernatants bearing
mutant envelopes were removed and infected with wild-type virions
with polybrene.
M
a
o
the his
94 PANDA, KINGSMAN, AND KINGSMANprocess of infectivity (Bae et al., 1997; Battini et al., 1995).
FIG. 3. Direct binding assay on NIH 3T3 cells by FACS analysis. X-a
for each histogram, and the numbers represent the corresponding amin
(A) Studies with virions bearing envelopes with single mutations; faint
histograms represent virions bearing envelopes with mutations, and
Studies with virions bearing envelopes with double and triple mutations
histograms with dark border lines represent WT MoMuLV virions, and
different double and triple mutations.organ et al. (1993) have identified a region between
mino acids 81 and 88 that plays a critical role in binding
a
af the SU to its receptor. A single point mutation in
resents the log of fluorescence, the Y-axis represents the cell number
numbers in the envelope gp70 that were mutated (see text for details).
ams represent negative controls (virions carrying no envelopes), dark
ams with solid border lines represent the WT MoMuLV particles. (B)
histograms represent negative controls (virions bearing no envelopes),
tograms with faint border lines represent virions with envelopes withxis rep
o acid
histogr
histogr
, darkspartate 84 and double mutations in arginines 83
nd 95 in MoMuLV gp70 have been reported to yield
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95MUTATIONAL ANALYSIS OF ENVELOPE PROTEIN IN ECOTROPIC RETROVIRUSnoninfectious particles (Bae et al., 1997; MacKrell et al.,
996).
To identify amino acids in SU that interact with its
eceptor, we have made mutations in the putative-recep-
or-binding domain of MoMuLV gp70. A region from
mino acids 89 to 100 was chosen for the above study.
he effect of various envelope mutations studied is sum-
arized in Table 2. None of the point mutations in the
nvelope protein abolished viral infectivity completely.
utations in amino acids 94 and 100 resulted in a thou-
and- and hundredfold reduction in viral titer, respec-
ively (Table 1). The reduction in viral titer in P94S might
ave been a result of a low level of envelope incorpora-
ion into particles (see Fig. 2A). Double or triple mutants
nvolving amino acid 100 resulted in loss of viral infec-
ivity as no blue cells were detected in the lacZ trans-
uction assay.
In this study, the only parameter changed in the infec-
ion process was the envelope protein. Hence it was
hought that the less or noninfective nature of the virions
earing the mutant envelopes could have resulted from a
oss of binding between the mutant envelopes and their
ell surface receptors or a defective process of fusion
nd/or postfusion steps. Here, we have been able to
iscriminate among mutations in MoMuLV gp70 that
esult in a range of effects using transduction and FACS-
FIG. 3inding assays. From all the point mutations created,
nly two mutant envelopes (P94S and W100T) resulted in
f
Mloss of viral titer, whereas the double and triple mutants
nvolving these two residues abolished the viral infectiv-
ty completely. It is likely that multiple interactions exist
etween the amino acids of the envelope and that of the
eceptor. Disruption of any individual interaction by
mino acid mutations might produce changes in affinity
hat are too small to be observed in a virus-based trans-
uction assay. Envelope proteins bearing mutations in
mino acids 89, 92, and 94 bind to the receptors with
ess efficiency than the wild-type virions. Interestingly,
he binding studies using these above mutant envelopes
re not reflected by viral titers. Viral particles with less
han wild-type affinity might still have sufficient opportu-
ity to bind to a cell to allow transduction. Mutation in
mino acid W100 produces an envelope that retains very
ittle binding affinity to its receptor. There is a possibility
hat W100 provides a point of contact between gp70 and
ts receptor. The fact that all mutants involving amino
cid W100 significantly reduced or abolished viral infec-
ivity provides evidence for this hypothesis. Recently
avey et al. (1999) have shown that W102 in Friend MuLV
p70 plays an important role in receptor interaction that
urther substantiates our result regarding the important
ole of W100 in Moloney gp70. From the above data, we
ould like to propose that the process of binding might
ot be a limiting factor for achieving wild-type titers in our
inuedunctional assays. A similar result was reported by
acKrell et al. (1996), who found that certain mutations in
96 PANDA, KINGSMAN, AND KINGSMANFIG. 4. Cell fusion (syncytia) on murine XC cells by different mutant and wild-type envelope proteins. A–K represent mutant envelopes pRV 730–pRV
740 (see text for details), L-WT MoMuLV gp70, and M-mock transfected cells.
—Cont
97MUTATIONAL ANALYSIS OF ENVELOPE PROTEIN IN ECOTROPIC RETROVIRUSamino acids 83, 86, and 87 produced wild-type titers but
the binding to cellular receptors was far too low in
comparison to the wild-type particles.
The incorporation of gp70 in viral particles was not
affected by mutations except when amino acid 94 was
changed where a significant loss of gp70 expression
was observed. The viral titer was not reduced to the
extent of the gp70 incorporation in mutant particles in-
volving this amino acid. This might be due to the fact that
any change in proline 94 altered the structure of the
region between R83 and R95, thereby altering its antige-
nicity.
FIG. 4In all gp70 mutations, titers were restored to wild-
type levels upon superinfection with WT virions.There is a possibility that mutant envelope pro-
teins could bind to the receptor far less effectively, i.e.,
less tightly than their wild-type counterparts. This
could mean that the mutant proteins, due to their low
affinity for receptor binding, were easily displaced at
the time of reinfection, thereby giving easy access
to the wild-type envelope proteins. Hence, we are
tempted to conclude that all the receptor molecules
expressed on the cell surface were utilized by the
wild-type proteins that could not be used by the mutant
proteins due to their low binding affinity. Further struc-
tural analysis and binding studies between purified
inuedmutant envelope proteins and their receptors would
resolve this issue.
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98 PANDA, KINGSMAN, AND KINGSMANMATERIALS AND METHODS
Construction of envelope mutants
Mutations were introduced in the wild-type envelope
gene (pHIT 123, (Soneoka et al., 1995) by using a recom-
binant PCR technique (see Fig. 5). An external primer, 59
CCG GAA TTC CGG ATG GCG CGT TCA ACG CTC 39,
was designed to bear an EcoRI site (underlined) that has
omplementarity with the 59 end of the wild-type enve-
ope gene. The other external primer used was 59 TCT
AG TCg gat ccC AAA TGT AAG 39, which has a BamHI
ite (lowercase letters). The sequences of the internal
rimers used for creating different envelope mutants
ere as follows: L89P forward, 59 CCA GAG ACT GCG
AG AAC CTC CAA CCT CCC TCA CC 39; L89P reverse,
9 GCA CCG AGG GGT GAG GGA GGT TGG AGG TTC
TC GCA G 39; T90V forward, 59 AGA GAC TGC GAA GAA
CT TTA GTC TCC CTC ACC CC 39; T90V reverse, 59 GTT
CA CCG AGG GGT GAG GGA GAC TAA AGG TTC TTC
TABLE 2
Summary of the Effect of Envelope Mutations on Their Expression
n Virions, Viral Infectivity, Binding to Cellular Receptors, and Fusion
o XC Cells
Envelope used
Titer
(CFU/ml)a
gp70
expression
in virionsb
Binding to
NIH 3T3
cellsb
Fusion to
XC cellsb
pHIT 123 1.3 3 106 1111 1111 111
T
RV 730 9.6 3 105 1111 111 111
89P
RV 731 1.4 3 106 1111 1111 111
90V
RV 732 2.2 3 106 1111 1111 111
91A
RV 733 1.2 3 106 1111 11 11
92P
RV 734 1.2 3 106 1111 1111 111
93V
RV 735 9.6 3 103 1 11 1
94S
RV 736 9.6 3 104 1111 6 1
100T
RV 737 1.2 3 103 1111 6 1
91A/W100T
RV 738 0 1111 6 6
93V/W100T
RV 739 0 1 6 6
94S/W100T
RV 740 0 1111 6 2
89P/P94S/W100T
ock 0 2 2 2
a Titers represented are the mean 6 SD of the replicated determi-
nants from a representative experiment of a total of three performed.
b The effect of envelope mutations was compared to the virions
carrying WT envelope proteins (1111).9; S91A forward, 59 GAC TGC GAA GAA CCT TTA ACC
CC CTC ACC CCT CGG 39; S91A reverse, 59 AGT GTTCA CCG AGG GGT GAG GGC GGT TAA AGG TTC 39;
92P forward, 59 TGC GAA GAA CCT TTA ACC TCC CCC
CC CCT CGG TGC 39; L92P reverse, 59 GGC AGT GTT
CA CCG AGG GGT GGG GGA GGT TAA AGG 39; T93V
orward, 59 GAA GAA CCT TTA ACC TCC CTC GTC CCT
GG TGC AAC 39; T93V reverse, 59 CCA GGC AGT GTT
CA CCG AGG GAC GAG GGA GGT TAA 39; P94S for-
ard, 59 GAA CCT TTA ACC TCC CTC ACC TCT CGG
GC AAC ACT 39; P94S reverse, 59 GTT CCA GGC AGT
TT GCA CCG AGA GGT GAG GGA GGT 39; W100T
orward, 59 ACC CCT CGG TGC AAC ACT GCC ACG AAC
GA CTC AAG 39; W100T reverse, 59 CTG GTC TAG CTT
AG TCT GTT CGT GGC AGT GTT GCA 39.
Both primary and secondary amplification reactions
ere carried out using Pfu turbo polymerase (Strat-
gene) at an annealing temperature of 60°C. The sec-
ndary PCR products were digested with EcoRI and
amHI, inserted into pBluescript KS(1) (Stratagene)
loning vectors, and sequenced. The final fragments
ere assembled in a mammalian expression vector that
ontains the cytomegalovirus promoter and the simian
irus 40 origin of replication (Soneoka et al., 1995). The
nvelope plasmids bearing point mutations were named
RV 730–pRV 736.
The double and triple mutant envelope plasmids were
onstructed by using the plasmid containing the point
utations as templates in the amplification reactions.
he plasmid bearing a mutation at one amino acid was
sed as template and sets of oligonucleotides bearing a
utation at another amino acid were used as primers.
he sequences of double and triple mutants were con-
FIG. 5. Recombinant PCR method. Primary amplification reactions
were performed using one of the internal primers (X or Y) that bear a
mutation and an overlapping end along with an external primer (A or B).
The arrowhead shows the direction of amplification. In the secondary
amplification reaction, only the external primers were used. The restric-
tion sites designed for cloning purposes are represented as overhangs
in the external primers during the primary amplification reactions.
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99MUTATIONAL ANALYSIS OF ENVELOPE PROTEIN IN ECOTROPIC RETROVIRUSfirmed by DNA sequencing. The envelope plasmids
bearing double and triple mutations were named pRV
737–pRV740.
Cell lines, transfection, production of viruses, and
transduction assay
NIH 3T3 (Anderson, 1979), XC (Rowe et al., 1970), and
293T cells (DuBridge et al., 1987) (obtained from Professor
David Baltimore, Rockefeller University) were grown in Dul-
becco’s modified Eagle’s medium (Sigma) supplemented
with 10% fetal calf serum and appropriate antibiotics. Virus
was produced by three-plasmid cotransfection by the
CaPO4 method as described previously (Soneoka et al.,
995) with 10 mg each of envelope expression plasmid,
Gag-Pol expression plasmid pHIT 60 (Soneoka et al., 1995),
and retroviral lacZ expression plasmid pHIT 111 (Soneoka
et al., 1995). The cells were treated with sodium butyrate the
next day at a final concentration of 10 mM and left for 12 h.
Finally the cells were washed with phosphate-buffered sa-
line (PBS) and refed with 5 ml of fresh medium. Viral su-
pernatants were collected 12 h later and filtered through
0.45-mm-pore-size filters for functional analysis.
NIH 3T3 cells were seeded on six-well culture dishes
at a density of 2 3 105 per well the day before the
transduction assay. The transduction assay was per-
formed by infecting cells with 1 ml of viral supernatants
(or with appropriate dilutions) with 8 mg of polybrene per
milliliter for 4 h before 2 ml of fresh medium was added
to each well. Viral titer was determined by counting the
number of X-Gal-positive cells after staining as de-
scribed previously (Soneoka et al., 1995).
Virus superinfection assay
NIH 3T3 cells were infected with virus carrying each of
the mutant envelope proteins for 3 h at 37°C. Then the
cells were superinfected with viruses carrying wild-type
envelope proteins with 8 mg of polybrene per milliliter.
The ability of the wild-type virions to superinfect NIH3T3
cells was determined by counting X-Gal-positive blue
cells.
Fusion assay
293T cells were grown to 70% confluence on 6-cm-
diameter dishes and transfected with either individual
mutant or wild-type envelope expression plasmid by
CaPO4 transfection and treated with sodium butyrate.
he next day the cells were harvested and cocultivated
ith 106 XC cells on 6-cm-diameter dishes. Cell fusion
as observed 24 h later with methylene blue staining
nd was photographed.
rotein analysis by Western blottingTransfected cells were washed in PBS and harvested
n REPA buffer (Maniatis et al., 1989) with 1 mM phenyl-ethylsulfonyl fluoride (Sigma). Total protein expressed
n the cell was quantified by using the BCA reagent (BCA
nc., USA). Protein samples were prepared for both cell
xtracts and viral supernatants before being analyzed on
he SDS–polyacrylamide gel. Equal quantities of proteins
rom the cell extracts and equal amounts of viral super-
atants were loaded onto the SDS–polyacrylamide gel
with both the stacking and the resolving gels) along with
he molecular weight markers. The particles were cen-
rifuged at 16,000 g for 30 min before being used for
Western blot analysis. Then the gel was transferred to
the Immobilon (Millipore) membrane and blocked over-
night at 4°C with 5% defatted milk containing 0.1% Tween
20 (Sigma). The blots were probed with goat anti-gp69/71
primary antibody (Quality Biotech Inc., Camden, NJ) at
1:3000 dilutions in the blocking solution for 1 h at RT.
After being probed, the blots were washed thrice with
0.5% milk containing 0.01% Tween 20 for 10 min each.
Then the blots were probed with the peroxidase-conju-
gated secondary antibody (Vector Laboratories) at 1:1000
dilutions for 1 h at RT. The blots were washed for 20 min
twice in the same washing solution as above followed by
a wash in PBS containing 0.01% Tween 20. The blots
were finally washed in PBS before being developed
using the ECL kit (Amersham).
Binding studies with fluorescence-activated cell
sorter
NIH 3T3 cells (106 in number) were trypsinized with
rypsin–EDTA solution (Sigma) and washed with wash
uffer containing PBS, 0.2% fetal calf serum, and 0.05%
odium azide. Following washing, the cells were incu-
ated with 1 ml of virus supernatants at 4°C for 1 h and
hen the cell pellet was treated with goat anti-gp69/71
rimary antibody (Quality Biotech Inc.) for 1 h at 4°C.
ubsequently the cells were washed three times with
old wash buffer and treated with the secondary rabbit
nti-goat FITC-conjugated antibody (Vector Laborato-
ies). Finally the cells were washed twice with cold wash
uffer and used to study the fluorescence using FACS-
an (Becton Dickinson).
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